Mariner Independent Advisor Network’s abrdn Life Sciences Investors HQL Stock Holding History

Mariner Independent Advisor Network’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-14,431	Closed	-$210K	–	339
2020 Q1	$210K	Buy	14,431 +187	+1%	+$3.06K	0.02%	346
2019 Q4	$248K	Sell	14,244 -747	-5%	-$12.3K	0.02%	355
2019 Q3	$226K	Buy	14,991 +42	+0.3%	+$673	0.02%	365
2019 Q2	$252K	Buy	+14,949	New	+$246K	0.02%	353
2019 Q1	–	Sell	-20,134	Closed	-$313K	–	364
2018 Q4	$313K	Buy	20,134 +5,885	+41%	+$104K	0.03%	332
2018 Q3	$290K	Buy	+14,249	New	+$283K	0.04%	214

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Mariner Independent Advisor Network's HQL Position: Q2 2020 in Review

Mariner Independent Advisor Network sold out of abrdn Life Sciences Investors (HQL) in Q2 2020, closing a stake of 14,431 shares — an estimated $210K sold.

Mariner Independent Advisor Network first reported a position in HQL in Q3 2018 and held it in 6 quarters. The position peaked at $313K in Q4 2018. 70 funds tracked by Wall St. Rank hold HQL as of Q2 2020.

Mariner Independent Advisor Network reported no remaining abrdn Life Sciences Investors position as of Q2 2020 after selling out during the quarter.
Mariner Independent Advisor Network sold 14,431 abrdn Life Sciences Investors shares in Q2 2020, an estimated $210K.
Mariner Independent Advisor Network first reported a position in abrdn Life Sciences Investors in Q3 2018 and held it in 6 quarters.
Mariner Independent Advisor Network's abrdn Life Sciences Investors position peaked at $313K in Q4 2018.
70 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2020.

Based on Mariner Independent Advisor Network's 13F filing for Q2 2020, filed 3 Aug 2020.